A phase I/II study to assess the safety, tolerability and pharmacolkinetics (PK) of intravenous (IV) infusion of MB07133 in subjects with unresectable hepatocellular carcinoma (HCC).
Other conference paper


Full Text

Times Cited
Web of Science2WOS source URL (as at 22/10/2020) Click here for the latest count

Other information
All Author(s) ListMa B, Forbes W, Venook AP, Bissell DM, Peterson C, Niculae I, Bullough D
Name of Conference42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Start Date of Conference02/06/2006
End Date of Conference06/06/2006
Place of ConferenceAtlanta
Country/Region of ConferenceUnited States of America
Journal nameJournal of Clinical Oncology
Year2006
Month6
Day20
Volume Number24
Issue Number18
PublisherAMER SOC CLINICAL ONCOLOGY
Pages92S - 92S
ISSN0732-183X
eISSN1527-7755
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-23-10 at 00:19